Loading...
Loading...
Loading...
Loading...
Try browsing our complete catalog of products.
No reviews have been added for this product.
Atlas Antibodies
Atlas Antibodies


| Product Specifications | |
| Application | IHC, ChIP-Exo-Seq |
| Reactivity | Human |
| Clonality | Polyclonal |
| Host | Rabbit |
| Immunogen | EPVSFHDPQGNPGLAYSPQDYQSAKPALDSNLFPMIPDYNLYHHPNDMGSIPEHKPFQGMDPIRVNPPPITPLETIKAFKDKQIHPGFGSLPQPPLTLKPIRPRKYPNRPSKTPLHERPHACPAEGCDRRFSRSD |
| Gene Sequence | EPVSFHDPQGNPGLAYSPQDYQSAKPALDSNLFPMIPDYNLYHHPNDMGSIPEHKPFQGMDPIRVNPPPITPLETIKAFKDKQIHPGFGSLPQPPLTLKPIRPRKYPNRPSKTPLHERPHACPAEGCDRRFSRSD |
| Gene ID - Mouse | ENSMUSG00000033730 |
| Gene ID - Rat | ENSRNOG00000017828 |
| Buffer | 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. |
| Documents & Links for Anti EGR3 pAb (ATL-HPA006206) | |
| Datasheet | Anti EGR3 pAb (ATL-HPA006206) Datasheet (External Link) |
| Vendor Page | Anti EGR3 pAb (ATL-HPA006206) at Atlas Antibodies |
| Documents & Links for Anti EGR3 pAb (ATL-HPA006206) | |
| Datasheet | Anti EGR3 pAb (ATL-HPA006206) Datasheet (External Link) |
| Vendor Page | Anti EGR3 pAb (ATL-HPA006206) |
| Citations for Anti EGR3 pAb (ATL-HPA006206) – 1 Found |
| Pio, Rebecca; Jia, Zhenyu; Baron, Veronique T; Mercola, Dan. Early growth response 3 (Egr3) is highly over-expressed in non-relapsing prostate cancer but not in relapsing prostate cancer. Plos One. 8(1):e54096. PubMed |


| Product Specifications | |
| Application | IHC, ChIP-Exo-Seq |
| Reactivity | Human |
| Clonality | Polyclonal |
| Host | Rabbit |
| Immunogen | EPVSFHDPQGNPGLAYSPQDYQSAKPALDSNLFPMIPDYNLYHHPNDMGSIPEHKPFQGMDPIRVNPPPITPLETIKAFKDKQIHPGFGSLPQPPLTLKPIRPRKYPNRPSKTPLHERPHACPAEGCDRRFSRSD |
| Gene Sequence | EPVSFHDPQGNPGLAYSPQDYQSAKPALDSNLFPMIPDYNLYHHPNDMGSIPEHKPFQGMDPIRVNPPPITPLETIKAFKDKQIHPGFGSLPQPPLTLKPIRPRKYPNRPSKTPLHERPHACPAEGCDRRFSRSD |
| Gene ID - Mouse | ENSMUSG00000033730 |
| Gene ID - Rat | ENSRNOG00000017828 |
| Buffer | 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. |
| Documents & Links for Anti EGR3 pAb (ATL-HPA006206) | |
| Datasheet | Anti EGR3 pAb (ATL-HPA006206) Datasheet (External Link) |
| Vendor Page | Anti EGR3 pAb (ATL-HPA006206) at Atlas Antibodies |
| Documents & Links for Anti EGR3 pAb (ATL-HPA006206) | |
| Datasheet | Anti EGR3 pAb (ATL-HPA006206) Datasheet (External Link) |
| Vendor Page | Anti EGR3 pAb (ATL-HPA006206) |
| Citations for Anti EGR3 pAb (ATL-HPA006206) – 1 Found |
| Pio, Rebecca; Jia, Zhenyu; Baron, Veronique T; Mercola, Dan. Early growth response 3 (Egr3) is highly over-expressed in non-relapsing prostate cancer but not in relapsing prostate cancer. Plos One. 8(1):e54096. PubMed |